Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.
Vaccine
; 40(49): 7014-7021, 2022 11 22.
Article
in En
| MEDLINE
| ID: mdl-36283896
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tetanus Toxoid
/
Meningococcal Vaccines
/
Meningococcal Infections
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Vaccine
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos